Welcome to Novo Nordisk in the United States

file

About the author:

Novo Nordisk discovers and develops innovative medicines and makes them accessible to patients throughout the world. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of products and delivery systems for diabetes care, as well as in other therapeutic areas where the company can make a difference. Novo Nordisk, Inc., is the US affiliate of Novo Nordisk A/S. We are one of the world’s leading diabetes care company. The company’s US headquarters are located in Plainsboro, NJ, and the Novo Nordisk US business presence stretches from coast to coast -- from an insulin manufacturing plant in North Carolina to the Novo Nordisk Research Center in Seattle, WA.

Entries by Novo Nordisk US

    Money, Medicine and Mercy

    19 October 2017

    We all sympathize with those who are suffering the devastation of natural disasters over the past weeks – Hurricanes Maria, Harvey and Irma, and the wildfires in California. Life may never be the same for many people.

    Read more

    An update on our efforts to help those in need…

    18 September 2017

    As we continue to see more and more unimaginable images from the largest US natural disaster ever, our hearts ache for everyone affected by the recent hurricanes in Texas, Louisiana, Florida, and the Caribbean. 

    While all of our employees in these areas are safe and accounted for, many experienced catastrophic flooding, home and property damage and related hardships. Many are still struggling with power and transportation issues and assessing the effect on their local communities, including our customers and partners, and the patients they serve. 

    Read more

    Our Hearts are with Houston

    29 August 2017

    The devastation caused by Hurricane Harvey in Houston hits close to home for us at Novo Nordisk. Houston is the first city where we established our Cities Changing Diabetes Program in the U.S. and where we currently employ people who dedicate each of their days to bringing change to diabetes patients. These employees, and the patients we serve, may currently be displaced from their homes as a result of the damage and ensuring their safety as well as assisting the many individuals in need in the Houston area is mission critical.

    Read more

    Our perspectives on pricing and affordability

    30 November 2016

    We hear from more and more people living with diabetes about the challenges they face affording healthcare, including the medicines we make. We take this issue seriously and have been thinking about what we can do to better support patients. This has become a responsibility that needs to be shared among all those involved in healthcare and we’re going to do our part. 

    Read more